Please use this identifier to cite or link to this item: https://www.um.edu.mt/library/oar/handle/123456789/150944
Title: Identification of single chain antibodies targeting lung tumour associated antigens by phage display
Authors: Chircop, Elisa (2026)
Keywords: Lungs -- Cancer
Lungs -- Cancer -- Immunotherapy
Bacteriophages
Recombinant proteins -- Therapeutic use
Issue Date: 2026
Citation: Chircop, E. (2026). Identification of single chain antibodies targeting lung tumour associated antigens by phage display (Bachelor's dissertation).
Abstract: The second leading cause of mortality in the world is currently lung cancer, and available treatments, such as chemotherapy and radiotherapy, cause severe toxicity. Immunotherapies such as monoclonal antibodies, vaccines, and Chimeric Antigen Receptor (CAR) T-cells enable a more targeted therapeutic approach. Currently, immunotherapies for non-small cell lung carcinomas (NSCLC) have shown progress; despite this, there is still a high rate of drug resistance and low response rates. There are various techniques to develop antibodies, including hybridoma technology and phage display; however, hybridoma technology can cause allergies, has a risk of contamination and is time consuming. This raises the question whether phage display can be used to identify high-affinity singlechain fragment variables (scFvs) specifically targeting selected tumour-associated antigens (TAAs). The aim of this project was to develop and validate scFvs that specifically home to the molecular targets Mucin-1 and Carcinoembryonic antigen 5 (CEA5). This was done by carrying out biopanning against these TAAs to obtain an enriched scFv-phage library. Moreover, validation of the enriched libraries’ specificity to the TAAs was done using Enzyme-Linked Immunosorbent Assay (ELISA). Monoclonal scFvs were isolated and validated against their respective TAA by ELISA. Their nucleotide sequences were obtained using Sanger, followed by homology modelling and cluster analysis to compare and analyse the clones. No amplification of the phage library was observed during biopanning against MUC1, whereas biopanning against CEACAM5 yielded an enriched polyclonal phage library. Thirty monoclones were isolated from the CEACAM5-enriched library; two were high binders and contained the full scFv structure, two were non-specific binders without the full sequence present, and two were short non-binding clones. Cluster analysis revealed that nearly all isolated clones had unique Complementarity Determining Regions (CDRs), responsible for antigen-specific binding. Future work involves computational analysis of the clone structures to understand flexibility and conformation in relation to the epitopes. Moreover, convertiƟng scFvs into full-length antibodies and antibody-drug conjugates (ADCs) enables the development of new immunotherapies for lung cancer.
Description: B.Sc. (Hons)(Melit.)
URI: https://www.um.edu.mt/library/oar/handle/123456789/150944
Appears in Collections:Dissertations - FacHSc - 2026
Dissertations - FacHScABS - 2026

Files in This Item:
File Description SizeFormat 
2608HSCMLS420000016184_1.PDF
  Restricted Access
7.62 MBAdobe PDFView/Open Request a copy


Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.